MDX-1401

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDX-1401, covering 2012-12-06 to 2012-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma [Phase 1]